Another stable methylated peptide, cCGNNMeGRG, targeted the pure APN enzyme with 15-fold higher potency than cCNGRC, and imaging studies with a radiolabeled version displayed higher tumor selectivity in melanoma-bearing mice over cCNGRC. Here, ANPEP is linked to neoplasm.